Richard Hudson, Representative of North Carolina, announced that he and 81 bipartisan colleagues have urged the U.S. Food and Drug Administration (FDA) to take action against unsafe Chinese drug imports, including counterfeit medications, to safeguard consumers. “The statement was made on X,” Hudson said.
“92% of Trump voters agree: The FDA must crack down on unsafe Chinese drugs,” said Richard Lane Hudson, U.S. Representative from North Carolina. “That’s exactly why I led 81 bipartisan colleagues in demanding action to stop these dangerous imports and protect American consumers.”
U.S. officials have expressed concerns about counterfeit anti-obesity medications such as semaglutide and tirzepatide entering the country from unregulated Chinese suppliers. These drugs are often mislabeled as “research use only.” According to Reuters, the FDA and 38 state attorneys general warn that these drugs may be contaminated, inaccurately dosed, or unsafe due to their unknown origins.
In April 2025, the FDA seized hundreds of counterfeit Ozempic injection pens found in the U.S. supply chain. The FDA reported that affected products had falsified lot and serial numbers. While six adverse events were reported, none were confirmed to be linked to the counterfeits.
U.S. Customs and Border Protection (CBP) recently intercepted 54,843 counterfeit drug products, including Ozempic and tirzepatide, valued at over $3.5 million. According to CBP, these items were seized in Cincinnati during joint inspections with the FDA aimed at combating illicit medication imports.
Hudson has represented North Carolina’s 9th District since 2013 and serves on the House Energy and Commerce Committee. According to Wikipedia, his focus includes economic growth, job creation, and national security.
